Nicolas Leupin, Chief Medical Officer at NovoCure Ltd (NVCR), sold 991 shares at $20.55 ($20K) on 2025-02-27, disclosed to the SEC on 2025-03-03.
Open-market sale of $20k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.92 | 830 | $17K | 83.3% |
| 2 | $20.55 | 161 | $3K | 16.7% |
| Total | $20.02 avg | 991 | $20K | 100% |
| Filing → |